Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Stone

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
Biomedicines|March 28, 2024
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial IschemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic MyocardiumDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
JTCVS Open|September 19, 2024
Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary diseaseDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Cells|February 12, 2026
Cellular and Molecular Mechanisms of SARS-CoV-2 Spike Protein-Induced Endothelial DysfunctionKelsey C Muir, Dwight D Harris, Meghamsh Kanuparthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemiaDwight Douglas Harris, Christopher Stone, Mark Broadwin, et al.
Journal of the American College of Surgeons|January 30, 2024
Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor CanagliflozinDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
International Journal of Molecular Sciences|March 13, 2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic SyndromeDwight D Harris, Mark Broadwin, Christopher Stone, et al.
Journal of the American College of Cardiology|October 3, 2003
Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillationJoseph L Blackshear, W Dudley Johnson, John A Odell, et al.
Aging and Disease|August 3, 2021
Limb Remote Ischemic Conditioning Ameliorates Cognitive Impairment in Rats with Chronic Cerebral Hypoperfusion by Regulating Glucose TransportChanghong Ren, Yuanyuan Liu, Christopher Stone, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
Biomedicines|March 28, 2024
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial IschemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic MyocardiumDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
JTCVS Open|September 19, 2024
Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary diseaseDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Cells|February 12, 2026
Cellular and Molecular Mechanisms of SARS-CoV-2 Spike Protein-Induced Endothelial DysfunctionKelsey C Muir, Dwight D Harris, Meghamsh Kanuparthy, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemiaDwight Douglas Harris, Christopher Stone, Mark Broadwin, et al.
Journal of the American College of Surgeons|January 30, 2024
Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor CanagliflozinDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
International Journal of Molecular Sciences|March 13, 2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic SyndromeDwight D Harris, Mark Broadwin, Christopher Stone, et al.
Journal of the American College of Cardiology|October 3, 2003
Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillationJoseph L Blackshear, W Dudley Johnson, John A Odell, et al.
Aging and Disease|August 3, 2021
Limb Remote Ischemic Conditioning Ameliorates Cognitive Impairment in Rats with Chronic Cerebral Hypoperfusion by Regulating Glucose TransportChanghong Ren, Yuanyuan Liu, Christopher Stone, et al.
Pageof 8